David Tapke, MD
Allergy & Immunology · Cincinnati, OHNPI 1033523253
Payments from drug & device makers
Across 695 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- AstraZeneca$2K
- GSK$2K
- Amgen$1K
- Allerderm Laboratories$1K
- Grifols USA, LLC$921
- plus $6K from 33 others
What the payments were for
- Consulting fees$1,5029%
- Travel & lodging$160%
- Food & beverage$14,40184%
- Education$1,2137%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 108 | $3,905 |
| AstraZeneca | 94 | $2,316 |
| GSK | 150 | $2,313 |
| Amgen(2 entities) | 35 | $1,027 |
| Allerderm Laboratories | 1 | $1,000 |
| Grifols USA, LLC | 48 | $921 |
| Novartis | 41 | $767 |
| Pfizer | 35 | $647 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $618 |
| Alk-abello, Inc | 14 | $310 |
| Octapharma USA, Inc. | 15 | $306 |
| Optinose US, Inc. | 12 | $278 |
| AbbVie | 6 | $270 |
| Blueprint Medicines Corporation | 6 | $249 |
| CSL Behring | 6 | $234 |
| Covis Pharma GmbH | 11 | $229 |
| Genentech USA, Inc. | 11 | $212 |
| Regeneron Healthcare Solutions, Inc. | 8 | $204 |
| Kaleo, Inc. | 8 | $123 |
| Boehringer Ingelheim | 8 | $119 |
| Pharming Healthcare, Inc. | 3 | $115 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $107 |
| Sanofi-aventis U.S. LLC | 2 | $102 |
| Hospira, Inc. | 5 | $97 |
| ADMA Biomanufacturing LLC | 8 | $96 |
| Teva Pharmaceuticals USA, Inc. | 6 | $95 |
| GC Biopharma USA, Inc. | 4 | $78 |
| LEO Pharma Inc. | 3 | $61 |
| Biocryst US Sales Co., LLC | 2 | $55 |
| Hikma Pharmaceuticals USA | 2 | $41 |
| Galderma Laboratories, L.p. | 1 | $37 |
| Eyevance Pharmaceuticals LLC | 2 | $31 |
| Bio Products Laboratory USA, Inc. | 2 | $28 |
| Incyte Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Invivyd Inc | 1 | $24 |
| Jubilant Hollisterstier LLC | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,132 in reported general payments places this provider in the 75th percentile of 128 allergy & immunology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 35 | $204,567 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 14 | $119,156 |
| Dupixent PenDupilumab | 27 | $98,925 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $59,935 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 26 | $52,527 |
| Dupixent SyringeDupilumab | 13 | $50,697 |
| Breo ElliptaFluticasone/Vilanterol | 54 | $42,710 |
| Arnuity ElliptaFluticasone Furoate | 29 | $12,041 |
| Advair HfaFluticasone Propion/Salmeterol | 27 | $11,984 |
| DuleraMometasone/Formoterol | 27 | $10,262 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 53 | $9,133 |
| Qvar RedihalerBeclomethasone Dipropionate | 14 | $6,391 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 29 | $4,466 |
| Azelastine Hcl | 122 | $4,357 |
| Pulmicort FlexhalerBudesonide | 13 | $3,898 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bio Products Laboratory USA, Inc.Gammaplex | $28 | $204,56735 claims |
| CSL BehringHizentra | $234 | $119,15614 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $2,313 | $114,686142 claims |
| Grifols USA, LLCGamunex-C | $921 | $52,52726 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $95 | $6,39114 claims |
| AstraZenecaPulmicort Flexhaler | $2,316 | $3,89813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 128 allergy & immunology providers in Ohio.
Other allergy & immunology in Cincinnati
- Jonathan BernsteinCincinnati$4.5M
- David BernsteinCincinnati$2.7M
- Justin GreiweCincinnati$1M
- Sheharyar DurraniCincinnati$953K
- Juan AboniaCincinnati$515K
- Gordon MyersCincinnati$346K
- Joshua BernsteinCincinnati$18K
- Jeffrey RaubCincinnati$14K
- John SeyerleCincinnati$8K
- Heather HartmanCincinnati$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.